Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatmentLuciano Anselmino(Consejo Nacional de Investigaciones Científicas y Técnicas), Mauricio Menacho-Márquez(National University of Rosario)Scientific ReportsApril 14, 202110.1038/s41598-021-87525-zCited by 35SaveCiteExport RISWatch citationsRelated PapersMetformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models|Oncotarget|2016|72Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers|Scientific Reports|2023|13